Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
13221
-
13222
-
13223
-
13224
PCAIs inhibit NCI-H23 cell line viability.
Published 2024“…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
-
13225
PCAIs disrupt actin filaments in NCI-H23 cells.
Published 2024“…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
-
13226
PCAIs suppress 3D NCI-H23 cell invasion.
Published 2024“…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
-
13227
PCAIs suppress NCI-H23 cancer cell migration.
Published 2024“…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
-
13228
PCAIs induce apoptosis in NCI-H23 cells.
Published 2024“…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
-
13229
-
13230
-
13231
Prevaelnce of different pathogens by location.
Published 2025“…<div><p>Diarrheal illness remains a major global health challenge, causing millions of deaths annually. …”
-
13232
-
13233
-
13234
-
13235
-
13236
Shaping the task allows the network to adapt to a large rotation angle (here ) even if the target size and the noise level are extremely small.
Published 2014“…<p><b>A.</b> Shaping by decreasing the target size, as explained in the text. …”
-
13237
-
13238
Image_3_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.tif
Published 2022“…We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”
-
13239
-
13240
Image_1_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.tif
Published 2022“…We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”